Somatic hypermutation (SHM), coupled with Ag selection, provides a mechanism for generating Abs with high affinity for invading pathogens. Class-switch recombination (CSR) ensures that these Abs attain pathogen-appropriate effector functions. Although the enzyme critical to both processes, activation-induced cytidine deaminase, has been identified, it remains unclear which cis-elements within the Ig loci are responsible for recruiting activation-induced cytidine deaminase and promoting its activity. Studies showed that Ig gene-transcription levels are positively correlated with the frequency of SHM and CSR, making the intronic, transcriptional enhancer Eμ a likely contributor to both processes. Tests of this hypothesis yielded mixed results arising, in part, from the difficulty in studying B cell function in mice devoid of Eμ. In Eμ's absence, V H gene assembly is dramatically impaired, arresting B cell development. The current study circumvented this problem by modifying the murine Igh locus through simultaneous insertion of a fully assembled V H gene and deletion of Eμ. The behavior of this allele was compared with that of a matched allele carrying the same V H gene but with Eμ intact. Although IgH transcription was as great or greater on the Eμ-deficient allele, CSR and SHM were consistently, but modestly, reduced relative to the allele in which Eμ remained intact. We conclude that Eμ contributes to, but is not essential for, these complex processes and that its contribution is not as a transcriptional enhancer but, rather, is at the level of recruitment and/or activation of the SHM/CSR machinery.
greatly improved our understanding of this process. AID activity is also required for the process of class-switch recombination (CSR) (4) . Although the efficiency of an Ab response is greatly augmented by SHM and CSR, mistargeting of these processes poses a significant threat to the integrity of the host cell's genome. In fact, AID has been implicated in tumorigenesis in a wide variety of tissue types (5, 6) . Fortunately, AID normally acts almost exclusively on Ig genes. Although it was shown that some non-Ig genes are subject to AIDinduced cytidine deamination (in B cells of normal mice and healthy humans), repair of these lesions is such that no mutation results or mutation occurs at rates at least an order of magnitude less than that at Ig loci (7) (8) (9) (10) (11) .
The means by which the SHM machinery is specifically directed to Ig loci remains unclear (reviewed in Refs. [1] [2] [3] . SHM preferentially targets RGYW/WRCY hot spots, but these hotspots can be found in almost any gene. Because V H sequences can be replaced with other DNA sequences without affecting the rate or extent of SHM, element(s) responsible for targeting must fall outside the region mutated but in cis with those sequences (12) . A strong promoter is required, but while an Ig promoter is not essential, not all other strong promoters will suffice (13, 14) . The tissue-specific transcriptional enhancers associated with the Ig loci have been implicated, but their importance in transgenes has not always been matched by an equivalent importance within the endogenous loci (15) (16) (17) (18) (19) . Furthermore, because transcription rate is positively correlated with SHM rate (13, 20) , it is difficult to parse whether enhancers serve to mark a locus for mutation (i.e., recruit the SHM machinery) and/ or increase the rate of mutation by simply increasing transcription (i.e., influence machinery activity subsequent to recruitment).
Enhancers have also been implicated in the control of CSR. Deletions affecting the 3′ regulatory region (3′RR) of the Igh locus dramatically reduce CSR (21) (22) (23) (24) . An important role was attributed to the intronic enhancer Eμ, when it was found that deletion of the core (cEμ) or the core and flanking matrix attachment regions (MARs) reduced CSR activity (25, 26) . However, in these early experiments, cEμ's essential role in V H gene assembly precluded CSR analyses of functional IgH genes; Eμ-deficient alleles were uniformly nonfunctional (no VDJ assembly) and were assessed for CSR only by assays for DNA rearrangements in and around the switch-μ (Sμ) region (27) (28) (29) (30) . In later studies, germline transmission of a cEμ-deficient allele allowed for the analysis of rare cEμΔ/cEμΔ B cells that had undergone monoallelic V H gene assembly in cEμ's absence (29) . As before, the nonfunctional, cEμ-deficient allele in these rare cells showed evidence of reduced CSR activity (measured by Sμ breaks/rearrangements). CSR and SHM took place on the functional (but cEμ-deficient) allele, but it was not possible to compare the rates of these processes with those on an allele that retained cEμ, because, when made heterozygous with a wild-type (WT) allele, the cEμ-deficient allele never became functional (no V-D-J assembly). Another caveat to assessing the effect of cEμ deletion on CSR and SHM in cEμΔ/cEμΔ mice was the possibility that the rare B-lineage cells that managed to form a functional IgH gene might have done so through compensatory mutations that supplanted Eμ function with respect to both V H assembly and SHM/CSR.
In the current study, we sought to circumvent the fundamental problem associated with studying Eμ's functions in processes that take place after V H gene assembly. The strategy taken was to generate and then directly compare matched Igh alleles that carried identical V H genes (V H knock-in) but retained Eμ (V H Eμ) or lacked Eμ (V H Δ). As described below, this comparison revealed a reduction in CSR and SHM upon Eμ deletion, but the effects observed were small and suggest considerable functional redundancy in the locus with respect to the regulation of these processes. Given that loss of Eμ did not result in decreased IgH gene transcription in mature, activated B cells, we further suggest that Eμ's role in SHM and CSR is not as a regulator of transcription but, rather, as one of the elements contributing to the recruitment of the SHM/CSR machinery to the Igh locus.
Materials and Methods
Mice V H Δ mice on a mixed C57BL/6J and 129/Ola genetic background were generated in our laboratory (31) and later backcrossed to mice with a C57BL/6J genetic background. Homozygous V H Eμ mice on a mixed CB.20 and 129/Ola genetic background were previously described as B1-8i mice (32) and were kindly supplied by Dr. Klaus Rajewsky (CBR Institute for Biomedical Research, Boston, MA). Mice carrying Igh alleles that lacked the J H gene segments and Eμ (denoted ΔJ H in the present studies) were on a C57BL/6J background and were obtained from The Jackson Laboratory (Bar Harbor, ME) (B6.129P2-Igh-J tm1Cgn /J; stock no. 002438) (25) . All mice were bred and maintained in animal facilities at Hunter College, City University of New York, in accordance with established guidelines of the Hunter College Institutional Animal Care and Use Committee. 1A) . PCRs were performed with high-fidelity PfuUltra Hotstart DNA polymerase (cat. no. 600390; Stratagene, La Jolla, CA), and products were cloned in pCR4Blunt-TOPO vector (cat. no. K2880-20; Invitrogen, Carlsbad, CA) for sequencing. Included in these studies were V H Eμ/WT mice (4), V H Δ/WT mice (5) , and V H Eμ/V H Δ mice (4).
SHM analyses
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were immunized once with 4-hydroxy-3nitrophenylacetyl chicken γ globulin (NP-CGG) or SRBCs and sacrificed 7 d later. Germinal center B cells were isolated as B220 + CD95 + PNA high cells from one V H Eμ/V H Δ mouse immunized with SRBCs; IgG + germinal center B cells were sorted as B220 + CD95 + IgG + cells from three V H Eμ/V H Δ mice immunized with SRBCs and two V H Eμ/V H Δ mice immunized with NP-CGG in alum.
V186.2-γ1 cDNA sequences-Three WT mice, four V H Δ/WT mice, and three V H Eμ/ WT mice were injected i.p. with 100 μg NP-CGG (Biosearch Technologies, Novato, CA; cat. no. N-5055) suspended in alum (Pierce, Rockford, IL; cat. no. 77161), according to the manufacturer's instructions. Mice were boosted one or two times, at 3-wk intervals. One week after the last injection, spleens were harvested, and RNA was extracted using a Qiagen RNeasy Mini kit (Qiagen, Valencia, CA; cat. no. 74104). V186.2-γ1 cDNAs were amplified by RT-PCR using a Qiagen one-step RT-PCR kit (Qiagen; cat. no. 210212) with primers V H 186.2F and Cγ1R, described previously (4) . V H 186.2F anneals to the V H 186.2 leader sequence, and Cγ1R anneals to CH1 of Cγ1, amplifying V186.2-γ1 transcripts expressed by both Igh alleles in V H Eμ/WT and V H Δ/WT B cells. WT allele transcripts were easily distinguished from those derived from the mutant alleles through analysis of the VDJ junction (unique sequence for B1-8 V H ) and presence/absence of an engineered mutation in the frame-work region 3 of the inserted B1-8 V H (T to C change at position 312 according to international ImMunoGeneTics numbering). Because there were no differences in the results obtained from animals boosted once versus twice with Ag, all data were pooled.
Computer analyses of DNA sequences-For sequences cloned from germinal center B cells, point mutations were analyzed in the 360-bp V H 186.2-DFL16.1-J H 2 coding sequences (exon) and the following 214-bp intron sequences ( Fig. 1A ). Total and synonymous mutations were identified in protein-encoding sequences (65.67 synonymous sites in V186.2 and 79.33 in V H 186.2-DFL16.1-J H 2). Synonymous sites were calculated with the Synonymous Non-synonymous Analysis Program (33) . For V182.2-γ1 cDNA sequences, only point mutations observed in the V186.2 region were analyzed, and the V-Quest program (available at http://imgt.cines.fr/) was used to analyze these sequences to identify the V H gene and mutations (34) .
Real-time RT-PCR
Total RNA was isolated with the RNeasy mini-prep kit (Qiagen; cat. no. 74106) from resting splenic B cells (enriched by negative selection using a B cell isolation kit from Miltenyi Biotec, Bergisch Gladbach, Germany; cat. no. 130-090-862;), splenic B cells stimulated by LPS for 48 h, or germinal center cells isolated from Peyer's patch (B220 + CD95 + PNA high ). Real-time RT-PCR analyses of VDJ-μ and VDJ-α mRNA expressed from the V H Eμ and V H Δ alleles were performed with the Qiagen QuantiTect SYBR Green RT-PCR kit (Qiagen; cat. no. 204243), using a 5′ primer specific for B1-8 V H (junction primer: 5′-CGCAAGATACGATTACTACGG-3′, anneals to VDJ junction of B1-8 V H ) and 3′ primers specific either for μ transcripts or α transcripts (primer sequences available upon request). RNA amounts were normalized with hgprt1 mRNA and were analyzed by the TaqMan, one-step RT-PCR kit (Applied Biosystems, Foster City, CA; cat. no. 4309169, TaqMan gene expression assay ID for hgprt1:Mm03024075_m1) or by the QuantiTect SYBR Green RT-PCR kit (Qiagen). Real-time RT-PCR reactions were performed on the 7500 Real-Time PCR System (Applied Biosystems) and analyzed with a program supplied by the manufacturer (User bulletin no. 2; http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf). Three mice of each genotype were used to quantify μ mRNA in LPS-stimulated B cells. For Peyer's patch germinal center cells, data were obtained from three pools of four to six V H Eμ/V H Eμ mice each and two pools of four to six V H Δ/V H Δ mice each.
Transcription rate comparisons by nuclear run-on assay
Methods used were essentially as described in Ref. 35 . Splenic B cells from four V H Eμ/ V H Eμ mice and from four V H Δ/V H Δ mice were stimulated in culture with LPS (25 μg/ml) for 3 d. Cells were harvested, and nuclei were isolated and incubated with 500 μCi α-[ 32 P]-UTP (6000 Ci/mmol, 10 mCi/ml) for 30 min. Isolated RNA (RNeasy mini-prep kit; Qiagen; cat. no. 74104) was hybridized to dot blots of the following plasmids (5 μg each): plasmid vector (negative control, pBluescript II SK + ), mouse actin cDNA (positive control), TOPO-V H (B1-8V H coding sequence), and TOPO-intron (the 214-bp sequence downstream of B1-8V H ). Hybridization was for 4 d with 2-6 × 10 6 cpm RNA in a total volume of 1 ml (Ultrahyb, Applied Biosystems; cat. no. AM8670). Blots were developed on a Typhoon 9410 phosphorimager (GE Healthcare, Piscataway, NJ), and dot intensities were quantified with ImageQuant software.
ELISA
Sera prepared from 3-11-mo-old mice (4 WT; 4 V H Eμ/ΔJ H ; 5 V H Δ/ΔJ H ; 6 homozygous V H Eμ/V H Eμ; 6 homozygous V H Δ/V H Δ mice) were analyzed for Ig isotype levels using a sandwich ELISA and standard methods. ρ-Nitrophenyl phosphate was used as substrate with alkaline phosphatase-conjugated Abs; ABTS was substrate for HRP-conjugated Abs.
Abs for the IgM, IgG1, IgG3, and IgE assays were purchased from BD Pharmingen (San Diego, CA), IgG2a and IgA assays were carried out with Zymed Abs (Invitrogen), and the IgG2b assay was carried out with Abs from Meloy (Springfield, VA) (detailed information on Abs available upon request).
Flow cytometry
Generally, cells were incubated at 4°C for 15 min in staining buffer (PBS, 5.6 mM glucose, 0.1% BSA, 0.1% NaN 3 ) with mAbs obtained from BD Pharmingen, except where indicated. FITC-conjugated reagents included Abs to mouse (IgM, IgM b , IgA, IgG1, IgG2a, IgG2b, IgG3, and IgE) and FITC-streptavidin. FITC-PNA was from Vector Laboratories (Burlingame, CA). PE-conjugated reagents included Abs to mouse (IgM a and CD95) and PE-streptavidin. PE-anti-mouse IgM was from eBioscience (San Diego, CA). Additional reagents were allophycocyanin-conjugated anti-mouse B220 and biotin-conjugated anti-IgG2a a and anti-IgG2a b . Cells were analyzed using FACS instruments (FACScan, FACSCalibur, and FACS-Vantage; BD Biosciences, San Jose, CA). Side and forward scatter were used to gate on lymphocytes, and dead cells were excluded by propidium iodide staining. All sorting was done using FACSVantage. Data were acquired with CellQuest or Pro CellQuest (FACS instruments) and then further analyzed with FlowJo software (Tree Star, Ashland, OR).
In vitro stimulation of splenic B cells and analysis
Resting splenic B cells were enriched by negative selection (Miltenyi Biotec; cat. #130-090-862). Experiments were performed in parallel on cells isolated from WT, V H Eμ/ V H Eμ, V H Δ/V H Δ, and V H Eμ/V H Δ mice. Cells were cultured for 3-5 d at 5 × 10 5 cells/ml in RPMI 1640 media supplemented with 20% FCS, 50 μM 2-ME, and 25 μg/ml LPS (Sigma-Aldrich, St. Louis, MO; cat. no. L6511), with or without the addition of cytokines: 10 ng/ml IL-4 (PeproTech, Rocky Hill, NJ; cat. no. 214-14), 100 ng/ml IFN-γ (PeproTech; cat. no. 315-05), or 1 ng/ml TGF-β (PeproTech; cat. no. 100-21R).
For CSR analyses shown in Fig. 3B , B cells were cultured for 5 d with LPS to stimulate switching to IgG3 and IgG2b, for 5 d with LPS + IL4 for switching to IgG1 and IgE, for 3 d with LPS + IFN-γ for switching to IgG2a, and for 3 d with LPS + TGF-β for switching to IgA.
For the stimulation of splenic μ a+ μ b+ double producers shown in Fig. 4A and 4B, splenic μ a+ μ b+ cells were isolated from V H Δ a /WT b mice (by flow cytometry) to a purity >98%. For assays of allele-specific class switching, cells were placed in culture with LPS (25 μg/ml), BAFF (10 ng/ml), and IFN-γ (100 ng/ml) for 5 d to induce switching to IgG2a, and cells were analyzed for the expression of IgG2a a and IgG2a b . C57BL/6 and V H Eμ/V H Eμ splenic B cells were included in these experiments for IgG2a b and IgG2a a allotype controls, respectively. Alternatively, stimulated B cells were analyzed for surface IgM a and IgM b 3 d after stimulation with LPS + IFN-γ and 5 d after stimulation with LPS + IL4.
For DNA analyses of V H Eμ/V H Δ B cells, enriched B cells were stimulated with LPS for 4 d, and B220, IgG3 + or B220, IgG3 − cells were isolated by flow cytometry. DNA was extracted from the sorted cells and analyzed by Southern blot for loss of a BamHI-EcoRI fragment that spans the switch-μ (Sμ) region, using previously described methods (31) . The μ Cregion coding sequence (Cμ) probe covered CH1 and approximately one half of CH2 (nt 1214283-1215005, 129/SvJ Contig NT_114985). Equal amounts of DNA were loaded in each lane, and ethidium bromide stains, as well as hybridization with a probe far downstream of the Igh 3′RR, were used to confirm equal loading (probe = nt 25343884-25345352, C57BL/6 Contig., NT_166318; detects 1.5-kb B/E fragment). Blots were developed on a PhosphorImager (Amersham Biosciences, Piscataway, NJ), and band intensities were quantified with ImageQuant software.
Results
We used gene targeting to insert a fully assembled V H gene, V H B1-8, into its natural position upstream of Cμ, while removing Eμ ( Fig. 1A) (31, 32) . The V H knock-in allowed us to circumvent the block to V H assembly (and B cell development) normally induced by Eμ removal (27) (28) (29) (30) . Mice heterozygous or homozygous for this modified Igh allele (designated V H Δ) had normal numbers of B cells in bone marrow, spleen, and Peyer's patches compared with a matched mouse strain with V H knock-in but Eμ intact (allele designated V H Eμ) (31, 32, data not shown). Given that the V H Eμ and V H Δ alleles carried the same V H promoter, V H sequence, and the same regulatory elements except for Eμ, a comparison of SHM and CSR in these two strains constituted a direct test of the effect of Eμ deletion on both.
The Eμ-deficient allele is highly mutated in germinal center B cells of Peyer's patch
To study the effect of Eμ deletion on SHM, we first analyzed the IgH genes of germinal center B cells isolated from Peyer's patches. B220 + CD95 + PNA high cells were isolated, and PCR was used to amplify V H B1-8 coding sequences ("exon" in Fig. 1A ) and 214 bp immediately downstream ("intron" in Fig. 1A) . The V H Eμ and V H Δ alleles are identical throughout the sequenced region (574 bp), but they can be differentially cloned using appropriate primers (no. 4 + no. 3 for V H Eμ; no. 4 + no. 2 for V H Δ allele) (Fig. 1A) . The alleles were compared in V H Eμ/WT and V H Δ/WT animals ( Supplemental Table I ) and in a more direct comparison in V H Eμ/V H Δ heterozygous mutant animals (Table I) .
As shown in Table I , the V H Δ and V H Eμ alleles in V H Δ/V H Eμ Peyer's patch cells sustained significant mutation. This finding is consistent with a previous study that demonstrated that SHM takes place at normal frequency on a V H knock-in allele (36) . However, there was a small, but significant, difference in mutation frequency between the V H Δ and V H Eμ alleles (p < 0.05; two-tailed t test and Mann-Whitney U test). The mutation frequency on the V H Δ allele was reduced relative to the V H Eμ allele within the exon (3.73 versus 5.14%) and the intron (2.14 versus 3.28%). A lesser mutation frequency for the V H Δ allele was also found in the Peyer's patch cells of V H Eμ/WT and V H Δ/WT animals, but the difference between the V H Δ and V H Eμ alleles generally lacked statistical significance ( Supplemental Table I ).
Germinal center cells were also analyzed in spleens of mice immunized with SRBCs or with the cognate Ag for B1-8V H and λ1 (the hapten NP in NP-CGG) (37, 38) . Mutation levels in splenic germinal center B cells were much less than those in the germinal center cells from Peyer's patches, as was reported previously (17) . Under both immunization conditions, the calculated mutation frequency was always lower within the V H exon of the V H Δ allele (for total and synonymous mutations), but the difference between this and the V H exon from the V H Eμ allele failed to reach statistical significance ( Supplemental Table II ).
Dramatic decrease in SHM on an Eμ-deficient allele in secondary response: IgG1producing B cells
We also examined the effect of Eμ deletion on SHM as revealed in a secondary response to Ag. In these experiments, mice were immunized with NP-CGG in alum and boosted one or two times at 3-wk intervals. As in the primary immunizations, NP-CGG was used in these experiments in an attempt to maximally recruit B1-8V H -expressing B cells into germinal centers. RNA was isolated from the spleens of immunized mice; a primer specific for the γ1 C region and another specific for V186.2 (the germline V H gene segment of B1-8V H ) were used to amplify V186.2-γ1 transcripts. Because γ1 transcripts derived from the V H Eμ and V H Δ alleles were indistinguishable, these experiments were carried out independently in V H Eμ/WT and V H Δ/WT mice rather than in V H Eμ/V H Δ mice.
As we demonstrated previously, a pronounced difference between V H Eμ a /WT b and V H Δ a / WT b mice is that in B cells from the former mouse strain, exclusion of the WT Igh b (WT b ) allele is almost complete, whereas in V H Δ a /WT b mice, ~20% of B cells express the modified allele and a fully assembled IgH gene on the WT Igh b allele (31, 32) . We showed that this difference in phenotype arises at the pre-B to immature B cell transition. For the present studies, this failure of allelic exclusion meant that in V H Δ a /WT b mice, we could measure SHM on two alleles expressed in the same mouse: one allele with and the other without Eμ.
To compare mutation frequencies for the V H Δ, WT, and V H Eμ alleles in the γ1 transcripts, only the V186.2 gene segment was analyzed (because only this region, and not D and J sequences, was shared among all three alleles). The unique V-D and D-J junction sequences of B1-8 V H and an engineered mutation in its frame-work region 3 served to unequivocally distinguish transcripts from the V H Eμ and V H Δ alleles from those deriving from the WT Igh b allele (31, 32) .
As summarized in Table II , 315 mutations were observed among 51 unique cDNA sequences cloned from WT mice, yielding an overall SHM frequency of 2.10%. This frequency is consistent with results from previous studies in WT mice, using a similar strategy (39) . In V H Eμ/WT mice, 250 mutations were found among 47 clones derived from the V H Eμ allele, yielding an overall mutation frequency on the V H Eμ allele (1.81%) that was similar to that of the WT Igh allele. Most, but not all, clones isolated from V H Eμ/WT mice were derived from the V H Eμ allele, consistent with the allelic exclusion observed in these animals (31) .
When heterozygous V H Δ/WT mice were analyzed, 93 V186.2-γ1 cDNA sequences derived from the V H Δ allele contained only 161 mutations (overall mutation frequency: 0.59%), representing a decrease in overall mutation frequency to one third that of the V H Eμ and WT alleles (p < 0.001; one-way ANOVA with posttest) (Table II ). Because we were also able to isolate cDNA sequences derived from the WT Igh b allele in the RNA samples prepared from these mice (presumably the products of double-producing, allelically included B cells), it was possible to compare, in the same animals, SHM on the V H Δ allele with that on the WT allele, where Eμ remained intact. Thirty-nine unique clones carrying V H 186.2 sequences and derived from the WT Igh b allele were isolated. They carried a total of 193 mutations, yielding an overall mutation frequency of 1.68%. This was significantly greater than the mutation frequency of the V H Δ allele from the same mice (p < 0.001). It was comparable to the mutation frequency of the WT alleles in WT mice and to the V H Eμ allele in V H Eμ/WT mice (Table II ) (i.e., SHM rates were normal on the WT allele of IgG1-producing V H Δ/WT B cells but were significantly reduced on the V H Δ allele).
In Peyer's patch cells of V H Δ/V H Eμ mice and in the IgG1 + B cells of immunized mice, the reduced mutation frequency on the V H Δ allele was largely attributable to an increase in clones with no mutation. Although, overall, the V H Δ allele accumulated smaller numbers of mutations than did the WT or V H Eμ alleles (Fig. 1B, 1C , pie charts), most striking was the larger proportion of clones derived from this allele that had sustained no mutation. Among the exon sequences analyzed in Peyer's patch cells of V H Δ/V H Eμ mice, 21% (9/42) were without mutation when derived from the V H Δ allele, whereas only 6% (3/49) lacked mutation when derived from the V H Eμ allele (p < 0.05) (Fig. 1B , Table I ). Similarly, 29% (12/42) of intron clones derived from the V H Δ allele showed no mutation, compared with 14% (7/49) from the V H Eμ allele (p < 0.1). Because the V H Eμ and V H Δ sequences were cloned from the same cell population, the difference in the proportion of unmutated sequences from the two alleles could not be explained by differences in cell-sorting purity. This pattern was also seen in the IgG1 transcripts recovered from V H Δ/WT cells. Although 41% of γ1 transcripts from the V H Δ allele had no mutations, only 3% of such transcripts derived from the other, WT allele, remained unmutated (Fig. 1C , Table II ). Together, these results suggest that the V H Δ allele is at a competitive disadvantage with respect to recruitment of the SHM machinery.
Eμ deletion does not affect the distribution or spectrum of mutations
Two hallmarks of SHM are its preference for RGYW/WRCY sequences (mutation hotspots) and its bias toward transitions (reviewed in Refs. [1] [2] [3] . Mutations in all alleles analyzed (in Peyer's patch germinal center B cells and splenic γ1 producers) were preferentially found within RGYW/WRCY sequences (40-50% mutations), and ≥50% were transitional mutations ( Supplemental Table III ). The base-exchange pattern was also analyzed, and the V H Δ allele showed the same mutation pattern as the other alleles analyzed ( Supplemental  Table IV ). In summary, the mutations recovered in these analyses were typical of SHM and did not differ in the absence of Eμ. μ mRNA level is not reduced in Eμ-deficient B cells SHM frequency was shown to positively correlate with transcription level (13) . For example, in the Igκ locus, deletion of the intronic enhancer (iEκ) had no effect on SHM frequency nor on transcription of assembled Igκ genes, but deletion of 3′Eκ reduced both (17) . By analogy, the small decreases in SHM seen upon Eμ deletion could be due to a concomitant decrease in transcription. We previously showed that surface IgM and μ mRNA levels in resting, splenic B cells are as high (or higher) in homozygous V H Δ mice as in homozygous V H Eμ mice (31) . To investigate the possibility that this might differ for activated B cells (undergoing SHM and CSR), we measured μ mRNA levels (by quantitative RT-PCR) in LPS-stimulated B cells and in germinal center cells isolated from Peyer's patches. As shown in Fig. 2A , μ mRNA levels were as high in V H Δ/V H Δ B cells as they were in V H Eμ/V H Eμ B cells, after LPS stimulation. In germinal center B cells (B220 + PNA high CD95 + ) isolated from Peyer's patches, V H Δ/V H Δ cells expressed as much μ mRNA and more α mRNA than did V H Eμ/V H Eμ germinal center B cells (Fig. 2B) .
Nuclear run-on assays were used to more directly measure the rate of transcription of the V H Δ and V H Eμ alleles. Nuclei were isolated from LPS-stimulated, splenic B cells from homozygous V H Δ/V H Δ and V H Eμ/V H Eμ mice, respectively. IgH transcripts that had been initiated before cell lysis were allowed to elongate in the presence of [ 32 P]-UTP, and the labeled, nascent transcripts were hybridized to an excess of DNA on filters. As shown in Fig. 2C , transcripts complementary to V H and intronic DNAs were as abundant in V H Δ/ V H Δ nuclei as they were in V H Eμ/V H Eμ nuclei, demonstrating no Eμ-dependent increase in IgH transcription rate in activated spleen cells (quantification of the signals yielded no statistically significant difference; data not shown).
These data, as well as our previously published studies of resting B cells, demonstrate that transcription of the Igμ gene created by B1-8iV H insertion does not decrease with Eμ deletion at the resting B cell stage nor after B cell activation. Therefore, any decrease in SHM seen upon loss of Eμ cannot be attributed to a decrease in transcription of the affected IgH gene.
CSR is less efficient in the absence of Eμ
As an indirect measure of CSR, we analyzed Ig isotype levels in the sera of hemizygous (V H Eμ/ΔJ H versus V H Δ/ΔJ H ) and homozygous (V H Eμ/V H Eμ versus V H Δ/V H Δ) mice. As shown in Fig. 3A , although IgM levels were not affected by Eμ deletion, the levels of almost all other isotypes were slightly lower in mice bearing the V H Δ allele (as measured by median value), but the difference between mice with the V H Eμ and V H Δ alleles reached statistical significance in only one case (IgG2a, homozygous animals, p < 0.05; Kruskal-Wallis test). IgG2b levels were lower than WT in V H Eμ/ΔJ H and V H Δ/ΔJ H hemizygous mice, with the decrease in V H Δ/ΔJ H mice reaching statistical significance (IgG2b; p < 0.05).
In a more direct measure of CSR, splenic B cells homozygous for the V H Eμ or the V H Δ allele were stimulated in vitro with LPS in combination with T cell-derived cytokines that promote IgH class switching (IL-4, IFN-γ, or TGF-β). As shown in Fig. 3B , the percentage of cells that switched from μ to another isotype did not differ significantly between homozygous V H Eμ and V H Δ B cells; however, in every case, there were more switched cells in the homozygous V H Eμ B cell cultures.
We took advantage of allelic inclusion in V H Δ a /WT b mice to directly compare CSR on the V H Δ a allele with CSR on the WT b allele. Double producers from these mice (μ a+ μ b+ ) were isolated by flow cytometry and then stimulated in vitro to induce CSR. Purity of the sorted μ a+ μ b+ cells was >98% (e.g., Fig. 4B ). Because allotype-specific Abs are available for IgG2a, μ a+ μ b+ cells were stimulated to switch to this isotype, and resulting cultures were analyzed to determine whether both alleles switched to IgG2a to the same extent. As shown in Fig. 4A , the anti-allotype Abs showed good specificity (control cultures consisted of Ig a / Ig a cells and Ig b /Ig b cells), and both alleles of the Ig a+b+ cells switched to the IgG2a isotype. The results of four independent experiments (spleens from two V H Δ/WT animals pooled in each experiment) showed consistently greater switching on the Ig b (WT) allele, but the difference was not statistically significant (Fig. 4A, graph) .
To look more broadly at switching on the two alleles, allele-specific loss of surface IgM was used as an indicator of CSR in another series of experiments. We reasoned that if the V H Δ a and WT b alleles switched at the same efficiency, switch-induced V H Δ a /WT b B cell cultures should generate a subpopulation negative for μ a and μ b (both alleles having switched to another isotype) and roughly equal subpopulations identified as μ a+ μ b− (CSR on WT b allele only) and μ a− μ b+ (CSR on V H Δ a allele only), respectively. However, as shown in Fig. 4B , after stimulation, a μ a+ μ b− sub-population (CSR on WT b allele only) was clearly evident, but no matching μ a− μ b+ subpopulation (CSR on V H Δ a allele only) was found. This suggested higher-efficiency switching on the allele that retained Eμ, although it is possible that the μ a+ μ b− cells in these cultures derived from contaminating single-producer cells. Arguing against this possibility was the purity of the beginning population (e.g., ~0.7% cells in μ a+ μ b− gate, Fig. 4B ), as well as the larger proportion of μ a+ μ b− cells in the cultures after stimulation (7-10% μ a+ μ b− cells; Fig. 4B ).
To directly compare the CSR efficiency of two alleles with the same IgH promoter and in a competing environment, we analyzed in vitro-stimulated V H Eμ/V H Δ B cells. In these experiments, CSR was measured by loss of an EcoRI/BamHI fragment that spans Sμ and, therefore, is lost upon CSR. This fragment is of different sizes on the two alleles (6.2 kb on V H Eμ allele, 8.3 kb on V H Δ allele; Fig. 4C ). When V H Eμ/V H Δ B cells are stimulated to switch isotype, the Sμ-region EcoRI/BamHI fragment should diminish in equal measure from the two alleles if both alleles are undergoing CSR at the same frequency. To test this, IgG 3 + and IgG 3 − cells were sorted from LPS-stimulated V H Eμ/V H Δ cells. DNA isolated from these cell populations was analyzed in Southern blots for the presence of the allelespecific EcoRI/BamHI fragments. As shown in Fig. 4C , both fragments were much more diminished in LPS/IgG3 + cells compared with V H Eμ/V H Δ liver cells (equal amounts of DNA were loaded in each gel lane, and a DNA probe hybridizing to sequences 3′ of the Igh locus served as a DNA loading control; Supplemental Fig. 1 ). Therefore, in most IgG3 + cells, both alleles had undergone CSR. In contrast, the ratio of the remaining fragments was changed from that of liver. Although the V H Δ fragment/V H Eμ fragment (and WT fragment/ V H Eμ fragment) ratio was 0.93-0.94 for liver DNA, it was 1.4 and 1.5 for IgG 3 + cells from V H Δ/V H Eμ mice (two independent experiments). DNA samples from the IgG 3 − cells, sorted side-by-side with the analyzed IgG 3 + cells, as expected, largely retained the Sμ-region EcoRI/BamHI fragments from both alleles (Fig. 4C) . The V H Δ/V H Eμ fragment ratios in DNA from these cells were similar to those for liver DNA (0.97/1.00). Therefore, as with SHM, CSR remains robust in the absence of Eμ; however, as also seen with SHM, an Eμdeficient allele seems to be at a disadvantage when competing with an allele that retains Eμ.
Discussion
A long-standing question regarding the SHM of Ig genes is how this machinery manages to target the Igh, Igκ, and Igλ loci, largely leaving other loci untouched (or at least unmodified) (reviewed in Ref. 40) . As one of the first tissue-specific, cis-control elements identified in the murine Igh locus, Eμ was an obvious suspect for recruiting the SHM machinery. The Eμ knockout/V H knock-in model used in the current study is particularly advantageous for testing that hypothesis. The V H Δ allele carries a functional V H , produces IgH chain at levels sufficient to drive B cell development and, therefore, generates normal numbers of peripheral B cells. A matched, Eμ-containing allele (V H Eμ) makes it possible to compare the behavior of alleles with and without Eμ, where the same DNA sequences (V H and intron) lie at the same distance from the same V H promoter. Moreover, as we have demonstrated, it is often possible to compare these alleles in the same mice and even in the same B cells. This contrasts with prior mouse studies involving Eμ deletion in which B cell development was impaired (in homozygous mutant mice), yielding a small and possibly unusual peripheral B cell compartment, or in which the mutant allele was always nonfunctional (heterozygous mutant mice) (25, 26, 29) .
Using the matched-allele system, we found that Eμ deletion results in a small, but significant, reduction in SHM frequency ( Fig. 1B, 1C , Tables I, II ). The reduced frequency of mutation on the V H Δ allele seems to be largely due to an increase in the proportion of such alleles that escape mutation altogether. The implication is that loss of Eμ results in significantly less efficient recruitment of the SHM machinery. However, once recruited, the pattern of mutation is indistinguishable from WT ( Supplemental Tables III, IV) . The increase in unmutated clones is not likely an artifact of cloning. Among clones with mutations, duplication was rare: only 1 mutated sequence was isolated twice among 56 unique, mutated sequences recovered from V H Δ/WT cells, suggesting that, similarly, the clones with no mutations were mostly independently derived (data not shown). It is also unlikely that the difference in mutation rates for the V H Δ and V H Eμ alleles was the result of Ag-driven selection processes that favor one allele over the other because their V H sequences are identical. Moreover, when only synonymous mutations within the V186.2 sequences of WT, V H Δ, and V H Eμ alleles were considered, the mutation rate remained significantly lower on the V H Δ allele (Table II) . The difference in mutation frequency for the V H Eμ and V H Δ alleles was less pronounced in Peyer's patch B cells compared with splenic IgG1 + cells, but this likely derives from the fact that with multiple rounds of exposure to the SHM machinery (as in Peyer's patch), less efficient targeting of the V H Δ allele becomes less evident as more clones join the ranks of the mutated.
Interestingly, an increase in the percentage of unmutated sequences was also observed in the earlier cited study of cEμ-deficient mice (29) . The investigators attributed this increase (relative to WT mice) to impaired B cell development (and the presence of fewer peripheral B cells), concluding that there was no real change in SHM. However, an alternate interpretation is that the cEμ-deficient allele, like the V H Δ allele of the current study, was less efficiently targeted by the SHM machinery for mutation; however, the already described drawbacks of the earlier experimental system made this difficult to confirm. Findings of a study of SHM in cell culture (hybridoma-expressing human AID) are consistent with the latter interpretation (cEμ deletion resulted in a significant reduction in SHM) (41) . However, inconsistent with our findings was the fact that SHM remained at normal levels when cEμ and its flanking MARs were deleted together. The Eμ deletion of the current study also included cEμ and its flanking MARs. However, two of the complicating factors in the cell culture studies were additional modifications made to the Igh locus in question (in addition to Eμ deletion) and the large variation in IgH gene expression seen among mutant clones (e.g., clones with the same mutation gave rise to IgM-producing and IgM-nonproducing subclones) (41) . In summary, previous studies provided hints that Eμ contributes to the efficiency with which the SHM machinery targets an expressed IgH gene; however, the current study, because of the more stringently controlled comparisons possible, gives greater power to that assertion.
Cloned V186.2-γ1 cDNA sequences from the V H Eμ allele included more unmutated sequences than did those from the WT alleles of WT mice (Table II) . This might reflect a partial impairment in SHM even for the V H Eμ allele (a developmental imprinting problem caused by a shorter stay at the pro-B cell stage as a consequence of V H knock-in?), but this interpretation is not supported by the fact that the V H Eμ allele was highly mutated (comparable to WT frequencies) in V H Eμ/V H Δ Peyer's patch B cells. Another possibility is that the B cells in WT/WT mice are under stronger selection pressure than are the B cells carrying a knock-in allele; consistent with this interpretation, when only synonymous sites were analyzed, the percentage of unmutated sequences from the WT and V H Eμ alleles did not differ appreciably.
Eμ's effect on SHM efficiency does not derive from its function as a transcriptional enhancer; transcripts from the V H Δ allele were as abundant as those from the V H Eμ allele, and transcription rate was indistinguishable between the two alleles within the sensitivity of a nuclear run-on assay (Fig. 2) . This is not a surprising finding, given that previous studies by us and other investigators showed that Eμ is not required to maintain high levels of IgH transcription in Ig-secreting cells (reviewed in Ref. 42 ). Eμ-independent transcription is explained by activity of the 3′RR, which becomes highly active as early as the immature B cell stage of development (43, 44) . It was proposed that the 3′RR is more important than Eμ in driving IgH transcription in the late stages of B cell maturation, and this recently found additional support in the phenotype of 3′RR-deficient mice in which Igμ transcripts were greatly decreased in unstimulated and LPS-stimulated splenocytes (in contrast to no decrease upon Eμ deletion) (24, 31; current study).
Because Eμ deletion does not result in a reduction in transcription rate, we conclude that Eμ's role in SHM is not secondary to its function as a transcriptional enhancer. This does not mean, of course, that transcription rate cannot affect SHM rate. This correlation has been well-established (e.g., Ref. 17) . Recently, deletion of the 3′RR was shown to decrease SHM within IgH genes, and it may well be that its influence on SHM is secondary to its effect on transcription (23, 24) .
Given the complexity of the endogenous Igh locus and the relatively small effects seen upon deletion of any individual cis-element, it is reasonable to conclude that there are many layers, and perhaps several redundant layers, to the regulation of SHM targeting (reviewed in Ref. 40) . Although replaceable, V H promoters might provide some specificity to the targeting process because not all strong promoters can support efficient SHM (14) . The 3′RR may influence SHM by way of its effect on IgH transcription in mature B cells (24) . Finally, the current study suggests that Eμ also contributes to SHM, but in this case it is not through its effect on IgH transcription. Rather, Eμ seems to be operating through a different mechanism, perhaps as a recruitment site/organizing center for attracting one or more components of the SHM machinery. It might be that all of these elements of the Igh locus, and perhaps others yet to be identified, culminate in the locus specificity of the SHM process.
The other aspect of Eμ function addressed in the present matched-allele study was Eμ's contribution to CSR. The suggestion that Eμ played a role in this process first arose from the analysis of Eμ-deletion chimeras (B cells heterozygous for Eμ deletion in RAG-2 knockout mice) and then the analysis of mice with germline Eμ mutation (25, 26, 29) . When made heterozygous with a WT allele, the Eμ-deficient allele was greatly impaired with respect to CSR-like recombination events. This suggested that Eμ was required for CSR, perhaps because of the Iμ promoter that lay within it. By analogy, knockout experiments removing the intronic promoters (Ips) for the germline transcripts associated with other C H genes led to selective deficiencies in CSR, affecting only the C H with the missing Ip (e.g., Ref. 45 ). However, unlike the Ips of other C H genes, Iμ is within the Igμ transcription unit so that transcripts initiating from the promoter of an assembled V H gene will, like Iμ transcripts, extend through the Sμ region. Therefore, it might be expected that IgH transcripts that result after V-gene assembly can supplant the need for Iμ transcripts. Consistent with this hypothesis, there was a severe defect in CSR on alleles that lacked Eμ and an assembled V H gene, whereas the current study revealed only a slight defect in CSR when a similar Eμdeficient allele was supplied with an assembled V H gene (and promoter). Interestingly, IgH transcripts through the Sμ region are much more abundant than are Iμ transcripts (35) .
However, Eμ deletion in the presence of an assembled V H gene is not innocuous with respect to CSR. We consistently observed suboptimal CSR on the V H Δ allele compared with Eμ-sufficient alleles (Figs. 3, 4 ). Although the mechanism through which Eμ supports optimal CSR is not immediately obvious, one possibility is that removal of the Iμ promoter changes the splicing pattern of μ transcripts and this, in turn, negatively affects CSR. The donor-splice site of the noncoding exon of Iμ transcripts lies close to Sμ (Fig. 1A) . This splice site remains on the ΔEμ allele, but it may rarely be used when in the presence of the donor-splice site at the border of a functional V H gene. Splicing has long been suggested to play a regulatory role in CSR, and a recent model emerged in which it is suggested that transcription and the subsequent recruitment of splicing factors serve to attract AID (35, 46, 47) . Perhaps the difference in proximity to Sμ of the two competing donor-splice sites (Iμ exon versus V H exon) translates to a difference in AID recruitment and CSR efficiency.
Alternatively, Eμ could affect CSR through its interaction with 3′RR. 3′RR is a primary regulator of CSR and physically interacts with the Eμ region in splenic B cells, as assessed by chromosome conformation-capture assay (48, 49) . Although Wuerffel et al. (48) showed that 3′RR continued to interact with an Eμ fragment minus the core (cEμ deletion), it is possible that the larger Eμ deletion of the current study (involving cEμ and flanking MARs) would have some effect on such cross-locus interactions and, thereby, influence the efficiency of CSR. SHM analysis of cDNA clones. Mice were immunized and boosted with NP-CGG. V186.2-γ1 cDNA was cloned from splenic RNA, sequenced, and analyzed for mutation (Materials and Methods).
